Search
for
Sort by
Research 481–510 of 1000+
- Anaemia and skin disease
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Hair loss
- On the geographies of hair: Exploring the entangled margins of the bordered body
- Symptom management in inflammatory bowel disease
- Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Post-finasteride syndrome – does it really exist?
- Proprietary Herbal Extract Downregulates the Gene Expression of Il-1 and #945; in HaCaT Cells: Possible Implications Against Nonscarring Alopecia
- Role of skin enzymes in metabolism of topical drugs
- COVID‐19, androgens, and androgenic alopecia
- Frontal fibrosing alopecia: A new autoimmune entity?
- Hyperadrenocorticism in Ferrets
- Structure and Function of the Skin
- Infertility: Evaluation and Initial Management
- Darier Sign: A Historical Note
- Ophthalmic manifestations of Demodex spp. infection – what should a dermatologist know?
- Acne
- Secondary amenorrhea
- Dermatological medications and local therapeutics
- Ottawa, Ontario, Canada, February 13–16, 2013
- Cognitive, emotional, physical, and behavioral stress-related symptoms and coping strategies among university students during the third wave of COVID-19 pandemic
- Steroid Hormones
- Telogen Effluvium
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Analysis of blood parameters and clinical features in women with pilonidal sinus disease: Is there a link between the disease and polycystic ovary syndrome?
- Debatable Topics in PCOS Patients
- Management of Toxicities of Targeted Therapies